DEER PARK, Ill., Feb. 06, 2025 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or...
Category - New Drug Applications
Odronextamab BLA Accepted for FDA Review for the Treatment of...
TARRYTOWN, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ:...